Literature DB >> 12559179

Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors.

Tom C Nguyen1, Taylor A Sohn, John L Cameron, Keith D Lillemoe, Kurtis A Campbell, JoAnn Coleman, Patricia K Sauter, Ross A Abrams, Ralph H Hruban, Charles J Yeo.   

Abstract

This study was designed to assess the health-related quality of life (QOL) of patients who had been randomly assigned to either standard or radical pancreaticoduodenectomy for periampullary adenocarcinoma. Pancreaticoduodenectomy has been performed in increasing numbers for periampullary adenocarcinoma. The appropriate extent of resection (standard vs. radical [extended]) remains controversial, particularly as concerns survival benefit. Past reports comparing standard vs. radical resection have suggested that the more extensive resection is attended by negative functional outcomes (diarrhea and weight loss) and poorer QOL, diminishing the impact of any possible survival advantage of the radical resection. A prospective, randomized single-institution trial comparing standard pancreaticoduodenectomy (pylorus preservation preferred) to radical pancreaticoduodenectomy (including distal gastrectomy and retroperitoneal lymphadenectomy) evaluated 299 patients with periampullary adenocarcinoma between April 1996 and June 2001. A standard Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) QOL survey designed for hepatobiliary cancer was sent to 150 of these patients surviving pancreaticoduodenectomy. QOL and functional status were assessed via a series of subscale scores for physical, social, emotional, and functional well-being. A total of 105 QOL surveys (70%) were returned and analyzed, with 55 of the patients having been randomized to the standard group and 50 to the radical group. The patients were evaluated at a mean of 2.2 years after pancreaticoduodenectomy. The two groups were statistically similar with regard to multiple parameters including age at operation (64.6 years), race, intraoperative blood transfusions, pathologic diagnosis and staging, and perioperative complications. The radical group had a significantly higher percentage of men (66% vs. 44%; P = 0.02), a longer operative time (369 minutes vs. 327 minutes; P < 0.001), and a longer postoperative length of hospital stay (13.6 days vs. 10.1 days; P < 0.01). The FACT-Hep total QOL scores were similar between the standard and radical groups: 143.5 vs. 147.3, respectively. Additionally, the individual FACT-G subscale scores evaluating physical (22.1 vs. 23.3), social (24.5 vs. 24.4), emotional (19.2 vs. 19.6), and functional well-being (20.6 vs. 22.4) were comparable between the standard and radical groups. Subgroup analyses based on pathologic diagnosis (pancreatic, ampullary, distal bile duct, etc.) failed to reveal any differences in QOL assessment between the standard and radical pancreaticoduodenectomy groups. Finally, QOL measures were similar when comparing time since operation (<2 years' follow-up vs. >2 years' follow-up) and age (< or =65 years vs. >65 years). This is the largest report comparing QOL assessment in survivors of pancreaticoduodenectomy randomized between standard and radical resection. These data demonstrate no differences in long-term QOL between standard and radical resection. These results imply that no negative long-term QOL measures are associated with radical pancreaticoduodenectomy (as performed in this study) for periampullary adenocarcinoma. Copyright 2003 The Society for Surgery of the Alimentary Tract, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12559179     DOI: 10.1016/s1091-255x(02)00187-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  28 in total

1.  Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas.

Authors:  K Satake; H Nishiwaki; H Yokomatsu; Y Kawazoe; K Kim; A Haku; K Umeyama; I Miyazaki
Journal:  Surg Gynecol Obstet       Date:  1992-09

2.  Evaluating quality-of-life in oncology patients: pilot observations.

Authors:  C A Presant; C Klahr; L Hogan
Journal:  Oncol Nurs Forum       Date:  1981       Impact factor: 2.172

3.  Quality of life and outcomes after pancreaticoduodenectomy.

Authors:  J J Huang; C J Yeo; T A Sohn; K D Lillemoe; P K Sauter; J Coleman; R H Hruban; J L Cameron
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

4.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

5.  Outcome analysis of long-term survivors following pancreaticoduodenectomy.

Authors:  W S Melvin; K S Buekers; P Muscarella; J A Johnson; W J Schirmer; E C Ellison
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

6.  Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure.

Authors:  R S McLeod; B R Taylor; B I O'Connor; G R Greenberg; K N Jeejeebhoy; D Royall; B Langer
Journal:  Am J Surg       Date:  1995-01       Impact factor: 2.565

7.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

8.  Pylorus-preserving Whipple resection for pancreatic cancer. Is it any better?

Authors:  A G Patel; M T Toyama; A M Kusske; P Alexander; S W Ashley; H A Reber
Journal:  Arch Surg       Date:  1995-08

9.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

10.  Results of extensive surgery for pancreatic carcinoma.

Authors:  T Nagakawa; M Nagamori; F Futakami; Y Tsukioka; M Kayahara; T Ohta; K Ueno; I Miyazaki
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

View more
  34 in total

1.  Incidence and outcome of biliary strictures after pancreaticoduodenectomy.

Authors:  Michael G House; John L Cameron; Richard D Schulick; Kurt A Campbell; Patricia K Sauter; Joann Coleman; Keith D Lillemoe; Charles J Yeo
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

Review 2.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

3.  Hospital readmission after pancreaticoduodenectomy.

Authors:  Dawn M Emick; Taylor S Riall; John L Cameron; Jordan M Winter; Keith D Lillemoe; Joann Coleman; Patricia K Sauter; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

4.  How surgeons make decisions: authority and evidence.

Authors:  Huug Obertop
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 5.  A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma.

Authors:  Markus K Diener; Hanns-Peter Knaebel; Christina Heukaufer; Gerd Antes; Markus W Büchler; Christoph M Seiler
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 6.  Delayed gastric emptying is associated with pylorus-preserving but not classical Whipple pancreaticoduodenectomy: a review of the literature and critical reappraisal of the implicated pathomechanism.

Authors:  Kosmas I Paraskevas; Costas Avgerinos; Costas Manes; Dimitris Lytras; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 7.  The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence.

Authors:  Michael B Farnell; Gerard V Aranha; Yuji Nimura; Fabrizio Michelassi
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

Review 8.  Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery.

Authors:  Manabu Kawai; Hiroki Yamaue
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

Review 9.  Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.

Authors:  Felix J Hüttner; Christina Fitzmaurice; Guido Schwarzer; Christoph M Seiler; Gerd Antes; Markus W Büchler; Markus K Diener
Journal:  Cochrane Database Syst Rev       Date:  2016-02-16

10.  Impact of the reconstruction method on delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: a prospective randomized study.

Authors:  Dietmar Tamandl; Klaus Sahora; Johannes Prucker; Rainer Schmid; Jens-Juul Holst; Johannes Miholic; Peter Goetzinger; Michael Gnant
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.